|

hEGFRvIII-CD3 (BRiTE) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BRiTE

Pipeline

Phase 1: 1

Top Sponsors

  • Mustafa Khasraw, MBChB, MD, FRCP, FRACP1

Indications

  • Newly Diagnosed Glioblastoma1
  • Recurrent Glioblastoma1
  • Cancer1

Durham, North Carolina1 trial

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Duke University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.